₹1,512.75-35.25 (-2.28%)
04:01 PM, 10-Feb-2026₹1,510.30-35.40 (-2.29%)
03:45 PM, 10-Feb-2026BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
Last Updated: 10-Feb-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 28,677 |
Traded Value (₹ Cr) | 0.78 |
Volume (Shares) | 5,156 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,585.50 |
52-Week High Date | 19-Jan-2026 |
52-Week Low (₹) | 890.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,585.50 |
All Time High Date | 19-Jan-2026 |
All Time Low (₹) | 890.00 |
All Time Low Date | 07-Apr-2025 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 28,631 |
| EPS - TTM (₹) [C] | 47.20 |
| P/E Ratio (X) [C] | 32.00 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.20 |
| Book Value Share (₹) [C] | 250.17 |
| P/B Ratio (₹) [C] | 6.04 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Nippon India Multi Cap Fund (G) | 313.34 | 21,40,625 | 0.64 |
| Nippon India Multi Cap Fund (IDCW) | 313.34 | 21,40,625 | 0.64 |
| Nippon India Multi Cap Fund (B) | 313.34 | 21,40,625 | 0.64 |
| Nippon India Multi Cap Fund - Direct (G) | 313.34 | 21,40,625 | 0.64 |
| Nippon India Multi Cap Fund - Direct (B) | 313.34 | 21,40,625 | 0.64 |
| Nippon India Multi Cap Fund - Direct (IDCW) | 313.34 | 21,40,625 | 0.64 |
| Aditya Birla SL ELSS Tax Saver Fund (IDCW) | 197.60 | 13,49,941 | 1.32 |
| Aditya Birla SL ELSS Tax Saver Fund (G) | 197.60 | 13,49,941 | 1.32 |
| Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) | 197.60 | 13,49,941 | 1.32 |
| Aditya Birla SL ELSS Tax Saver Fund - Direct (G) | 197.60 | 13,49,941 | 1.32 |
Load more
| Today's Low/High (₹) | 1,505.60 1,565.20 |
| Week Low/High (₹) | 1,461.10 1,565.20 |
| Month Low/High (₹) | 1,410.00 1,586.00 |
| Year Low/High (₹) | 889.00 1,586.00 |
| All time Low/High (₹) | 890.00 1,586.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 0.30% | 0.27% | 0.64% | 0.81% |
| 1 Month | -1.93% | -1.97% | 0.83% | 0.98% |
| 3 Month | 5.79% | 5.87% | 0.88% | 1.41% |
| 6 Month | 9.06% | 8.99% | 5.53% | 6.45% |
| 1 Year | 28.81% | 28.76% | 9.01% | 10.92% |
| 3 Year | - | - | 38.88% | 45.24% |
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA
Chairman (Non-Executive) : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,512.75 at 04:01 PM IST on 10th Feb 2026. Emcure Pharmaceuticals Ltd share price was down by 2.28% from the previous closing price of Rs 1,548.00. Emcure Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 28,677 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,585.50 and 52-week low share price is Rs 890.00.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 231.37 crore on a total income of Rs 2,365.33 crore for the quarter ended 2025.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt, Pfizer, Astrazeneca Phar.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows: